117 related articles for article (PubMed ID: 28266772)
1. Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: A nationwide survey.
Sato M; Tateishi R; Yasunaga H; Matsui H; Horiguchi H; Fushimi K; Koike K
J Gastroenterol Hepatol; 2017 Nov; 32(11):1873-1878. PubMed ID: 28266772
[TBL] [Abstract][Full Text] [Related]
2. In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database.
Sato M; Tateishi R; Yasunaga H; Matsui H; Fushimi K; Ikeda H; Yatomi Y; Koike K
BJR Open; 2019; 1(1):20190004. PubMed ID: 33178938
[TBL] [Abstract][Full Text] [Related]
3. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.
Sato M; Tateishi R; Yasunaga H; Horiguchi H; Yoshida H; Matsuda S; Koike K
J Gastroenterol; 2012 Oct; 47(10):1125-33. PubMed ID: 22426637
[TBL] [Abstract][Full Text] [Related]
4. Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.
Yeh CN; Lee WC; Chen MF
World J Gastroenterol; 2005 Apr; 11(14):2067-71. PubMed ID: 15810070
[TBL] [Abstract][Full Text] [Related]
5. Liver resection for hepatocellular carcinoma in patients with end-stage renal failure.
Cheng SB; Wu CC; Shu KH; Ho WL; Chen JT; Yeh DC; Liu TJ; P'eng FK
J Surg Oncol; 2001 Dec; 78(4):241-6; discussion 246-7. PubMed ID: 11745817
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of hepatocellular carcinoma in 14 patients undergoing regular hemodialysis for end-stage renal disease.
Kondo Y; Yoshida H; Tomizawa Y; Tateishi R; Shiina S; Tagawa K; Omata M
AJR Am J Roentgenol; 2009 Oct; 193(4):964-9. PubMed ID: 19770317
[TBL] [Abstract][Full Text] [Related]
7. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
[TBL] [Abstract][Full Text] [Related]
9. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
10. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
11. Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation.
Fujiwara N; Tateishi R; Kondo M; Minami T; Mikami S; Sato M; Uchino K; Enooku K; Masuzaki R; Nakagawa H; Kondo Y; Asaoka Y; Shiina S; Yoshida H; Koike K
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1039-46. PubMed ID: 25051219
[TBL] [Abstract][Full Text] [Related]
12. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
Patel AR; Dombrovskiy VY; Vogel TR
Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
[TBL] [Abstract][Full Text] [Related]
13. Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma.
Nouso K; Kariyama K; Nakamura S; Oonishi A; Wakuta A; Oyama A; Ako S; Dohi C; Wada N; Morimoto Y; Takeuchi Y; Kuwaki K; Onishi H; Ikeda F; Shiraha H; Takaki A; Okada H
J Gastroenterol Hepatol; 2017 Mar; 32(3):695-700. PubMed ID: 27597181
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A; Michitaka K; Horiike N; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Sogabe I; Ishimaru Y; Kawasaki H; Koizumi Y; Hirooka M; Yamashita Y; Abe M; Hiasa Y; Matsuura B; Onji M
J Gastroenterol Hepatol; 2010 Feb; 25(2):403-7. PubMed ID: 19929922
[TBL] [Abstract][Full Text] [Related]
16. Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.
Gupta T; Paul N; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Palaniswamy C; Sule S; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
J Am Heart Assoc; 2015 Jun; 4(6):e002069. PubMed ID: 26080814
[TBL] [Abstract][Full Text] [Related]
17. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395
[TBL] [Abstract][Full Text] [Related]
18. Surgical Fracture Repair in Chronic Renal Failure Patients on Hemodialysis An Analysis of Complications and Hospital Quality Measures.
Vaswani R; Manoli A; Goch A; Egol KA
Bull Hosp Jt Dis (2013); 2016 Jun; 74(2):160-4. PubMed ID: 27281322
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
